Addition of leukocytapheresis to steroid therapy: Is it beneficial in recurrence of moderate-to-severe ulcerative colitis?

Diseases of the Colon and Rectum

Volumn 46, Issue 10 SUPPL., 2003, Pages

  Jo, Yukihiko ^a   Matsumoto, Takayuki ^a   Mibu, Ryuichi ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Leukocytapheresis; Proctocolectomy; Ulcerative colitis

Indexed keywords

PREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; JAPAN; LEUKAPHERESIS; MALE; NONBIOLOGICAL MODEL; PROCTOCOLECTOMY; RECURRENT DISEASE; RISK FACTOR; STEROID THERAPY; SURGICAL RISK; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; COLONOSCOPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKAPHERESIS; MALE; PREDNISOLONE; PROCTOCOLECTOMY, RESTORATIVE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0142059232     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fiocchi C. Immune events associated with inflammatory bowel disease. Scand J Gastroenterol 1990;172:4-12.
2. Strober W, James SP. The immunologic basis of inflammatory bowel disease. J Clin Immunol 1986;6:415-32.
3. Schwab M, Schaffeler E, Marx C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002;12:429-36.
4. Falasco G, Zinicola R, Forbes A. Immunosuppressants in distal ulcerative colitis. Aliment Pharmacol Ther 2002;16:181-7.
5. Dwosh IL, Giles AR, Ford PM, Pater JL, Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis: a controlled, double-blind, crossover trial. N Engl J Med 1983 12;308:1124-9.
6. Miller FW, Leitman SF, Cronin ME, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992 21;326:1380-4.
7. Bicks RO, Groshart KD, Chandler RW. The treatment of severe chronically active Crohn's disease by T8 (suppressor cell) lymphapheresis (abstract). Gastroenterology 1985;88:A1325.
8. Bicks RO, Groshart KD. The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease. J Clin Gastroenterol 1989;11:136-8.
9. Sawada K, Ohnishi K, Kosaka T, et al. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1997;1:207-11.
10. Ayabe T, Ashida T, Kohgo Y. Centrifugal leukocyte apheresis for ulcerative colitis. Ther Apher 1998;2:125-8.
11. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001;16:1-9.
12. Kondo K, Shinoda T, Yoshimoto H, Takazoe M, Hamada T. Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis. Ther Apher 2001;5:462-5.
13. Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334-41.
14. Yajima T, Takaishi H, Kanai T, et al. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis. Ther Apher 1998;2:115-9.
15. Kohgo Y, Hibi H, Chiba T, et al. Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial. Ther Apher 2002;6:255-60.
16. Sawada K, Muto T, Shimoyama T, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-21.
17. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992;87:971-6.
18. Ohara M, Saniabadi AR, Kokuma S, et al. Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 1997;21:989-94.
19. Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-41.
20. Blackstone M. Endoscopic interpretation: normal and pathologic appearances of the gastrointestinal tract. New York: Raven Press, 1984.
21. Lerebours E, Bussel A, Modigliani R, et al. Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Gastroenterology 1994;107:357-61.
22. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
23. Kubota Y, Sawada T, Muto T. Controversy-surgical vs. medical management of inflammatory bowel disease. Nippon Geka Gakkai Zasshi 1992;93:1083-6.